- Lobbying
- jones AND public AND affairs
Lobbying Arrangements Results for 'Jones Public Affairs'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Update to PACE (Program of All-inclusive for the Elderly) regulations, flexibility in meeting federal requirements for transportation benefit and other requirements |
innovAge (Formerly Total Community Options Foundation)
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Legislation regarding tax reform and international tax issues. Issues relating to international business concerns. Free trade, generally. Legislation regarding alternative energy. |
Tyco Electronics
|
PODESTA GROUP, INC. | |||
Details Issues related to intellectual property protection; Issues regarding the implementation of tax reform as related to international taxes. Issues related to intellectual property protection; Issues r... |
Oracle
|
Forbes-Tate | |||
Details Various health care issues; Coordination of benefits; VA third party care. Medicare and Medicaid program integrity issues. Recovery Audit Contractors and program integrity. |
Health Management Systems, Inc.
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details - Telehealth issues - Workforce development; veterans' health care; Medicare reimbursement including "incident to" billing; Medicare hospice restrictions; transparency; opioid addiction treatment... |
American Academy of Physician Associates
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Center for Medicare and Medicaid Services proposed rules. H.R. 4302, Protecting Access to Medicare Act of 2014. Payment for home health services. Program integrity issues. |
Partnership for Quality Home Healthcare
|
PODESTA GROUP, INC. | |||
Details Issues related to criminal justice reform, H.R.2864 - Clean Slate Act of 2021 and S.1380 - Clean Slate Act of 2021. |
Futures Restored Inc.
|
UNITED BY INTEREST, LLC. | |||
Details International trade and protection of intellectual property; TRIPS Waiver; the Medical Supply Chain Resiliency Act; compulsory licensing and other IP issues in multiple countries. Advocate on drug ... |
GILEAD SCIENCES, INC.
|
in-house lobbying | |||
Details Implementation of section 224 of the Communications Act, as amended, regarding pole attachments. Privacy, including the American Data Privacy and Protection Act (H.R.8152). Rural Broadband Deployme... |
Comcast Corporation
|
in-house lobbying | |||
Details H.R. 2415 / S. 1184, Treat and Reduce Obesity Act of 2013. |
Eisai, Inc.
|
PODESTA GROUP, INC. | |||
Details Issues related to TSA PreCheck, other Trusted Traveler Programs, and the Registered Traveler program; FY2024 Department of Homeland Security Appropriations Act, H.R.4367/S.2625. Issues related to p... |
IDEMIA Identity & Security USA, LLC
|
Crossroads Strategies, LLC | |||
Details Issues regarding group purchasing organizations, drug pricing, drug shortages and health care delivery reform. |
Premier, Inc.
|
ALSTON & BIRD LLP | |||
Details Educate policymakers about company initiatives on benefits of wearable fitness technology; discuss use of aggregated data for public health monitoring. Monitor issues related to privacy legislation... |
Fitbit LLC (formerly Fitbit, Inc.)
|
Invariant LLC | |||
Details General tax matters affecting the shopping center industry including issues relating to like-kind exchanges and sales and use taxes; Marketplace Fairness Act (S 698); Remote Transaction Parity Act ... |
International Council of Shopping Centers, Inc.
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Budget issues associated with tax incentives for producing electricity from open loop biomass; Biomass Crop Assistance (BCAP). Tax incentives for producing electricity from biomass; Extenders Bill,... |
Biomass Power Association
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details STEM education. Cybersecurity and defense information technology. Department of Defense/Veterans' Affairs health records. H.R.2810/S. 1519 - National Defense Authorization Act for Fiscal Year 2018 ... |
Oracle Corporation
|
PODESTA GROUP, INC. | |||
Details Educate Members of Congress and Administration officials about reclaimed refrigerants and issues related to the implementation of P.L.116-260, The American Innovation and Manufacturing Act. |
Hudson Technologies
|
Invariant LLC | |||
Details CMS payment policy. |
Vital Care, Inc.
|
PODESTA GROUP, INC. | |||
Details Provide tax legislative and strategic advisory services with respect to legislative proposals to impose higher taxes on income from intangibles. |
Working Group on Intangibles (Informal Coalition)
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details IRC section 40 - second generation biofuels tax incentives |
Renewable Fuels Association
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Energy and tax issues related to Biomass and taxation of forestland and forestland companies |
National Alliance of Forest Owners
Alliance of forest owners |
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Tax issues in the American Recover & Reinvestment Act (HR 1) |
Liz Claiborne, Inc.
Retail apparel and accessories |
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Misc tax and energy incentives. DOE loan guarantee; HR 1; HR 1473. Misc. tax incentives; misc. energy tax incentives, DOE loan guarantee. |
Abengoa Solar
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details IRC Section 6426 and issues pertaining alternative fuel credit; renewable electricity and fuels generally; HR4389 IRC section 6426 and issues pertaining to alternative fuel mixtures credit; renewab... |
Lincoln Paper and Tissue LLC
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Duty drawback issues |
Distilled Spirits Council of the United States
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Health care issues associated with federal contractors, providers and payors |
Milliman Care Guidelines LLC
Evidence-based clinical guidelines |
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Energy tax incentives and related issues pertaining to recycling waste hydrocarbons and plastics and other renewable energy tax incentives Energy tax incentives and related issues pertaining to rec... |
Climax Global Energy
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details IRC Section 6426 and issues pertaining to alternative fuel mixtures credit; renewable electricity and fuels generally; HR4389 IRC section 6426 and issues pertaining to alternative fuel mixtures cre... |
Finch Paper, LLC
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details International tax issues, including territorial tax reform proposals. |
The Medical Device Competitiveness Coalition (Informal Coalition)
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions - antibiotic resistance). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug ... |
Cubist Pharmaceuticals, Inc.
|
PODESTA GROUP, INC. | |||
Details HR 4068 Canyon's Law - To prohibit the use of M-44 devices, commonly known as "cyanide bombs", on public land, and for other purposes. HR 6021 Ejiao Act of 2023 -- To prohibit the transportation... |
Animal Welfare Institute fka Society for Animal Protective Legislation
|
in-house lobbying | |||
Details Educate policymakers on pharmacy issues related to TRICARE and H.R. 2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to removing barriers to biosimilar medicine acce... |
CIGNA Corporation
|
Invariant LLC | |||
Details Enhance visibility of golf industry in Washington, D.C., monitor legislation impacting golf-related small businesses, and seek introduction of legislation beneficial to the golf industry. H.R. 2137... |
We Are Golf
|
PODESTA GROUP, INC. | |||
Details Auto industry issues (including sharing information about GM facilities, products, community programs, progress on GM restructuring, and responding to congressional inquiries concerning GM restruct... |
General Motors Company
|
PODESTA GROUP, INC. | |||
Details Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1837, "Investing in Our Communities Act". Proposals related to in... |
NATIONAL ASSN. OF STATE TREASURERS (NAST)
|
Williams and Jensen, PLLC | |||
Details Policies to ensure an adequate supply of blood plasma; Drug safety and drug counterfeiting; Policies affecting pre-existing condition protections; Drug importation; Policies impacting the U.S. res... |
Takeda Pharmaceuticals America, Inc.
|
Williams and Jensen, PLLC | |||
Details Issues related to the coverage of spiritual care. H.R. 2061 / S. 352 - EACH Act. |
Christian Science Committee on Publication
|
PODESTA GROUP, INC. | |||
Details Various issues related to administrative burden on school-based providers Various issues related to the Higher Education Act, specifically related to student loans, loan forgiveness, and accreditat... |
American Speech-Language-Hearing Association
|
in-house lobbying | |||
Details Issues related to the protection and access to public lands, including the Americas Outdoor Recreation Act of 2022 (S. 3266) and Outdoors For All Act (S. 2887/HR 5413). Issues related Fiscal Year 2... |
Recreational Equipment, Inc.
|
Signal Group Consulting, LLC | |||
Details General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug ... |
PFIZER
|
Williams and Jensen, PLLC | |||
Details Defense research, development and procurement. |
GENERAL DYNAMICS
|
PODESTA GROUP, INC. | |||
Details Monitor issues related to event safety, open internet, and broadband infrastructure. Support efforts to enact comprehensive live event ticketing reform, including, S.3457, Fans First Act and H.R.39... |
Eventbrite, Inc.
|
Invariant LLC | |||
Details - HR 3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 (the PATIENT Act) - HR 4507, Transparency in Coverage Act - HR 4822, Health Care Price Transparenc... |
Boeing Company
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Medicare sequester, PAYGO H.R. 2474, Strengthening Medicare for Patients and Providers Act: an annual inflation adjustment to Medicare physician payments S. 1512, CONNECT for Health Act of 2021: T... |
American Society of Anesthesiologists
|
in-house lobbying | |||
Details H.R. 6363: Further Continuing Appropriation and Other Extensions Act, 2024 - 2023 Farm Bill Reauthorization; provisions related to biofuels and sustainable aviation fuels H.R. 2670: National Defens... |
EXXON MOBIL CORP
|
in-house lobbying | |||
Details Public health funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control (CDC); Agency for Healthcare Research and Quality (AH... |
AMERICAN COLLEGE OF OBSTETRICIANS & GYNECOLOGISTS
|
OB-GYNS FOR WOMEN'S HEALTH | |||
Details H.R. 6 Support for Patients and Communities Act S. 2680 Opioid Crisis Response Act S. 2070 Kevin and Avontes Law H.R. 695 Minibus of seven remaining Appropriations Bills FY2019/H.R. 6157 Minibus wi... |
American Psychological Association
|
in-house lobbying | |||
Details FY24 Interior Appropriations (H.R. 4821/S. 2605) Advisory Council on Historic Preservation (ACHP) - Various issues related to implementation of National Historic Preservation Act and National Envir... |
National Trust for Historic Preservation
|
in-house lobbying | |||
Details Issues related to domestic and international tax. Public/private partnerships; cyber workforce; critical infrastructure regulations; space security; artificial intelligence; Inclusion and diversity... |
Accenture, LLP
|
in-house lobbying | |||
Details International and domestic tax issues. General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, an... |
Eli Lilly & Company
|
Williams and Jensen, PLLC |